{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Rosacea: Clinical Aspects and Treatments

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Distinguish the clinical manifestations of rosacea subtypes.
  2. Identify pharmacologic and nonpharmacologic treatment options for patients who have rosacea.

Learning Outcomes

Seventy-five percent of participants will demonstrate knowledge of rosacea clinical considerations by achieving a minimum score of 70% on the posttest.
Price: $24.95

Credits:

  • ANCC 2.5 CH / 1.5 APH
  • DC - BON 2.5 CH
  • FL - BON 2.5 CH
  • GA - BON 2.5 CH
  • NM - BON 2.5 CH
  • SC - BON 2.5 CH
  • WV - BOERN 2.5 CH

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Awarded Advanced Pharmacology Hours













Test Code: ASWC1223
Published: Dec 2023
Expires: 12/5/2025
Required Passing Score: 7/10 (70%)
Authors: Ryan Geng, MSc; Adrienn N. Bourkas, MSc; R. Gary Sibbald, MD, MEd, FRCPC (Med, Derm), FAAD, MAPWCA, JM
Topics: Rosacea